RT-PCR studies indicated that Myc, as well as BCL2, were significantly down regulated in PC3-AZD20 cells following treatment with CTA095 (Figure 12B), indicating that this down regulation may contribute to the induction of apoptosis in Src inhibitor resistant prostate cancer cells. The gene discussed is SRC; the disease is Familial prostate cancer.